CGT

868개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved868 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleHebei Taihe Chunyu Biotechnolog…Phase 1

CAR19-BCMA dual-target CAR-T (CAR19-BCMA dual-target CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 1

CAR19BCMA-T cells (CAR19BCMA-T cells)

Relapsed or Refractory Plasma Cell Neoplasms; Lymphomas/Leukemias With Plasmacytic Differentiation · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CAR19TIF cells (CAR19TIF cells)

B Cell Lymphoma · B Cell Lymphoma

#BCellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleSorrento Therapeutics, Inc.Phase 1

CAR2 Anti-CD38 A2 CAR-T Cells (CAR2 Anti-CD38 A2 CAR-T Cells)

Relapsed or Refractory Multiple Myeloma · CD38

#CD38#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleSorrento Therapeutics, Inc.Phase 1

CAR2 Anti-CEA CAR-T cells (CAR2 Anti-CEA CAR-T cells)

Metastatic Pancreatic Carcinoma · CEA

#CEA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleElicera TherapeuticsPhase 2

CAR20 (NAP, CAR20, CAR20(NAP)-T)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 2

CAR2219-T cells (CAR2219-T cells)

Relapsed or Refractory B Cell Leukemia and Lymphoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CARCCR9 T cells (CARCCR9 T cells)

T Cell Acute Lymphoblastic Leukemia; T Cell Lymphoblastic Lymphoma · T Cell Acute Lymphoblastic Leukemia

#TCellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

CARE T cells (CARE T cells)

Liver Cancer; Rhabdomyosarcoma · Liver Cancer

#LiverCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CART Infusion (CART Infusion)

Autoimmune Hemolytic Anemia; Primary Immune Thrombocytopenic Purpura · Autoimmune Hemolytic Anemia

#AutoimmuneHemolyticAnemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleYake Biotechnology Ltd.Phase 2

CART therapy (CART therapy)

Neuroblastoma (NB); Desmoplastic Small Round Cell Tumor (DSRCT) · Neuroblastoma (NB)

#NeuroblastomaNB#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhujiang HospitalPreclinical

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CART-138 cells (CART-138 cells)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CART-19/22 (CART-19/22)

Leukemia, B-cell · Leukemia, B-cell

#LeukemiaB-cell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

CART-38 (CART-38)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShanghai Simnova Biotechnology …Phase 1

CART-BCMA (CART-BCMA)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART-EGFR-IL13Ra2 T cells (CART-EGFR-IL13Ra2 T cells)

Recurrent Glioblastoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART-EGFRvIII T cells (CART-EGFRvIII T cells)

Patients With Residual or Reccurent EGFRvIII+ Glioma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CART-HER-2 (CART-HER-2)

Advanced HER-2 Positive Solid Tumors; Chemotherapy Refactory · Advanced HER-2 Positive Solid Tumors

#AdvancedHER-2PositiveSolidTumors#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleTceleron Therapeutics, Inc.Phase 1

CART-PSMA-TGFβRDN (CART-PSMA-TGFβRDN)

Metastatic Castration-resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued

21 / 44 pages

← PreviousNext →